On the other hand, Schoenfeld et al. [24] identified mutations of SMARCA4 in 8% of 4813 cases of NSCLC and categorized them into class 1 (truncating mutations, fusions, and homozygous deletion) and class 2 (missense mutations). This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.